Press release
Gabapentin Market CAGR to be at 4.37% | $3,036.38 Million Industry Revenue By 2032
๐๐๐๐๐ฉ๐๐ง๐ญ๐ข๐ง-๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ข๐ณ๐ ๐๐๐ฏ๐๐ง๐ฎ๐, ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ, ๐๐ง๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ ๐๐๐๐ฉ๐๐ง๐ญ๐ข๐ง ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐๐ฌ๐ญ๐ข๐ฆ๐๐ญ๐๐ ๐ญ๐จ ๐๐ ๐ฐ๐จ๐ซ๐ญ๐ก ๐๐๐ ๐,๐๐๐.๐๐ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐๐๐ข๐๐ญ๐๐ ๐ญ๐จ ๐๐ฑ๐ฉ๐๐ง๐ ๐ญ๐จ ๐๐๐ ๐,๐๐๐.๐๐ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐ฐ๐ข๐ญ๐ก ๐ ๐๐๐๐ ๐จ๐ ๐.๐๐% ๐๐ฎ๐ซ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐ข๐จ๐ ๐๐๐๐-๐๐๐๐.๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide gabapentin industry. It includes comprehensive analyses of sales volume, price, revenue, market share, and important companies. The market is further divided into segments by dosage, type, application, distribution channel, and region, offering a comprehensive picture of the gabapentin market state.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐ญ๐จ ๐๐๐ข๐ง ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ : https://www.polarismarketresearch.com/industry-analysis/gabapentin-market/request-for-sample
๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
Among other names, gabapentin is a brand-named anticonvulsant drug that is mostly prescribed to treat neuropathic pain and partial seizures. It is a drug that is frequently used to treat central pain, postherpetic neuralgia, and neuropathic pain brought on by diabetic neuropathy. The most frequent adverse effects are tiredness and lightheadedness. An increased risk of suicide, respiratory depression, and allergic reactions are examples of serious adverse effects. For people with renal illness, lower doses are advised. A subgroup of calcium channels had their activity reduced by gabapentin.
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐๐ง๐ ๐๐ซ๐๐ง๐๐ฌ:
โ As the population ages, chronic pain and neurological illnesses are predicted to become more common, increasing demand for drugs such as gabapentin.
โ The rise of e-commerce has made it easier for people to buy pharmaceuticals like gabapentin online, boosting access to the drug for patients who may not have easy access to a traditional pharmacy.
๐๐จ๐ฉ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ:
Because there are so many companies in the industry, it is expected to be both competitive and fragmented. Here are the top companies in the gabapentin market:
โข Pfizer Inc.
โข Teva Pharmaceutical Industries Ltd.
โข Sun Pharmaceutical Industries Ltd. Aurobindo Pharma Ltd.
โข Lupin Limited
โข Mylan N.V.
โข Cipla Limited
โข Hikma Pharmaceuticals PLC
โข Arbor Pharmaceuticals Inc.
โข Zydus Cadila Healthcare Limited
โข Glenmark Pharmaceuticals Ltd.
โข Apotex Inc.
โข Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd.
โข Wockhardt Ltd
๐๐ฅ๐ข๐๐ค ๐จ๐ง ๐ญ๐ก๐ ๐๐๐ฅ๐จ๐ฐ ๐๐ข๐ง๐ค ๐ญ๐จ ๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ : https://www.polarismarketresearch.com/buy/2178/2
๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐๐ข๐ฌ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:
According to regional research, the demand in North America is expected to witness significant growth during the forecast period. The demand for Gabapentin is expected to increase in various regions due to its efficacy and safety profile. Also, the Asia-Pacific region is expected to witness significant growth in the demand for gabapentin due to the increasing prevalence of neurological disorders, such as epilepsy and neuropathic pain. The rising healthcare spending and increasing awareness about the benefits of gabapentin are expected to drive the demand for the medication in the region.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
๐ฝ๐ฎ ๐ฟ๐ค๐จ๐๐๐ :
โข Capsule
โข Tablet
๐ฝ๐ฎ ๐๐ฎ๐ฅ๐ :
โข Branded
โข Generic
๐ฝ๐ฎ ๐ผ๐ฅ๐ฅ๐ก๐๐๐๐ฉ๐๐ค๐ฃ :
โข Neuropathic Pain
โข Epilepsy
โข Restless Legs Syndrome
โข Others
๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ซ๐๐ฏ๐ข๐๐ฐ: https://www.polarismarketresearch.com/industry-analysis/gabapentin-market
๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ซ๐๐ฏ๐ข๐๐ฐ:
๐๐ฅ๐๐ฉ๐๐๐ก๐ข๐๐ ๐ฟ๐ง๐ช๐๐จ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/ophthalmic-drug-market
๐๐ฎ๐๐จ๐ฉ๐๐๐ฃ๐๐ ๐๐ง๐๐ซ๐๐จ ๐ฟ๐๐จ๐๐๐จ๐ ๐๐ง๐๐๐ฉ๐ข๐๐ฃ๐ฉ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/myasthenia-gravis-disease-treatment-market
๐๐๐ช๐ง๐ค๐ก๐ค๐๐๐๐๐ก ๐ฝ๐๐ค๐ข๐๐ง๐ ๐๐ง๐จ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/neurological-biomarkers-market
๐๐ค๐ ๐๐๐๐๐๐๐ก ๐ฟ๐๐ซ๐๐๐๐จ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/iot-medical-devices-market
๐พ๐๐ก๐ก ๐ฟ๐๐จ๐จ๐ค๐๐๐๐ฉ๐๐ค๐ฃ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/cell-dissociation-market
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gabapentin Market CAGR to be at 4.37% | $3,036.38 Million Industry Revenue By 2032 here
News-ID: 3567124 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Mobile Biometrics Market is projected to reach USD 271.62 Billion by 2034, expan โฆ
The global mobile biometrics market is projected to be valued at approximately USD 53.10 billion in 2025 and is expected to witness strong growth through 2034, driven by rising concerns over data security, increasing smartphone-based digital transactions, and the growing adoption of biometric authentication across banking, enterprise, and government sectors. The market is anticipated to expand at a CAGR of 19.88% during the forecast period, reaching an estimated value ofโฆ
Global Bioregenerative Aesthetic Injectables Market Set for Strong Growth During โฆ
Polaris Market Research recently introduced the latest update on Bioregenerative Aesthetic Injectables Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the Bioregenerative Aesthetic Injectables Market size, share, demand, key growth factors, segmentation, country-level overview, and forecast.
The report helps businesses get a thorough understanding of theโฆ
Copper Mining Market Projected to Reach USD 235.28 Billion by 2034, Growing at a โฆ
Global Copper Mining Market is currently valued at USD 191.96 Billion in 2025 and is anticipated to generate an estimated revenue of USD 235.28 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 2.29% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026 - 2034
Polaris Market Research has introduced the latest market research report titled Copperโฆ
Specialty Oilfield Chemicals Market Projected to Reach USD 16.7 Billion by 2034, โฆ
Global Specialty Oilfield Chemicals Market is currently valued at USD 11.0 Billion in 2025 and is anticipated to generate an estimated revenue of USD 16.7 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 4.9% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026 - 2034
Polaris Market Research has introduced the latest market research report titledโฆ
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten โฆ
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailedโฆ
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva โฆ
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand theโฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โฆ
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingโฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โฆ
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asโฆ
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh โฆ
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theโฆ
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, โฆ
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoringโฆ
